Evidence map›Paper›PMID 40219788›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Somatic and Stem Cell Bank to study the contribution of African ancestry to dementia: African iPSC Initiative.

Mahmoud B Maina, Murtala B Isah, Jacob A Marsh, Zaid Muhammad, Larema Babazau, Abdulrahman Alkhamis Idris, Ekaterina Aladyeva, Nadia Miller, Emma Starr, Katherine J Miller and 7 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Somatic and Stem Cell Bank to study the contribution of African ancestry to dementia: African iPSC Initiative.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Mahmoud B MainaBiomedical Science Research and Training Centre, Yobe State University, Damaturu, Nigeria.
Murtala B IsahBiomedical Science Research and Training Centre, Yobe State University, Damaturu, Nigeria.
Jacob A MarshDepartment of Psychiatry, Washington University in St. Louis, St. Louis, Missouri, USA.
Zaid MuhammadBiomedical Science Research and Training Centre, Yobe State University, Damaturu, Nigeria.
Larema BabazauBiomedical Science Research and Training Centre, Yobe State University, Damaturu, Nigeria.
Abdulrahman Alkhamis IdrisBiomedical Science Research and Training Centre, Yobe State University, Damaturu, Nigeria.
Ekaterina AladyevaDivision of Neurogenetics, Department of Neurology, The Neuroscience Research Institute, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Nadia MillerDepartment of Psychiatry, Washington University in St. Louis, St. Louis, Missouri, USA.
Emma StarrDepartment of Psychiatry, Washington University in St. Louis, St. Louis, Missouri, USA.
Katherine J MillerDepartment of Psychiatry, Washington University in St. Louis, St. Louis, Missouri, USA.
Scott LeeDepartment of Psychiatry, Washington University in St. Louis, St. Louis, Missouri, USA.
Miguel MinayaDepartment of Psychiatry, Washington University in St. Louis, St. Louis, Missouri, USA.
Selina WrayDepartment of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
Oscar HarariDivision of Neurogenetics, Department of Neurology, The Neuroscience Research Institute, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Baba W GoniBiomedical Science Research and Training Centre, Yobe State University, Damaturu, Nigeria.
Louise C SerpellSussex Neuroscience, School of Life Sciences, University of Sussex, Brighton, UK.
Celeste M KarchDepartment of Psychiatry, Washington University in St. Louis, St. Louis, Missouri, USA.

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Project 4 (Genetic modifiers for APOE-associated Alzheimer's disease pathogenesis)U19AG069701 · NIA · MAYO CLINIC JACKSONVILLE · PI ALISON M GOATE · 2021 to 2026
$42.0M
MVP Data Integration into the ADSP Phenotype Harmonization ConsortiumU24AG074855 · NIA · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CUCCARO, MICHAEL L, HOHMAN, TIMOTHY J · 2021 to 2025
$37.5M
Research Education ComponentP30AG066444 · NIA · WASHINGTON UNIVERSITY · PI CHENGJIE XIONG · 2020 to 2026
$28.7M
Investigating the Functional Impact of AD Risk Genes on Neuro-Vascular InteractionsU01AG072464 · NIA · REGENERATIVE RESEARCH FOUNDATION · PI HARARI, OSCAR, KAMPMANN, MARTIN · 2021 to 2025
$8.7M
Human iPSC model of Cerebro-Vascular Interactions in ADRDR61NS138655 · NINDS · REGENERATIVE RESEARCH FOUNDATION · PI TEMPLE, SALLY · 2024 to 2024
$1.9M
Targeting Tau Proteoforms in Frontotemporal DementiaRF1NS110890 · NINDS · WASHINGTON UNIVERSITY · PI KARCH, CELESTE MARIE · 2021 to 2021
$1.8M
Targeting Tau Proteoforms in Frontotemporal DementiaR01NS110890 · NINDS · WASHINGTON UNIVERSITY · PI KARCH, CELESTE MARIE · 2024 to 2024
$575k
Targeting Tau Proteoforms in Frontotemporal DementiaR56NS110890 · NINDS · WASHINGTON UNIVERSITY · PI KARCH, CELESTE MARIE · 2019 to 2019
$558k
Molecular drivers of tauopathies in stem cell models from diverse human populationsK01AG083215 · NIA · WASHINGTON UNIVERSITY · PI Miguel Minaya · 2023 to 2026
$508k
Alzheimer's AssociationCare Research University College London Hospitals Biomedical Research CentreNational Institutes for HealthNCATS NIH HHS UL1 TR002345NIA NIH HHS AG083215NIA NIH HHS K01 AG083215NIA NIH HHS P30 AG066444NIA NIH HHS U01 AG072464NIA NIH HHS U19 AG069701NIA NIH HHS U24 AG074855NIH HHS K01 AG083215NIH HHS P30 AG066444NIH HHS RF1 NS110890NIH HHS U19 AG069701NIH HHS UL1TR002345NINDS NIH HHS NS110890NINDS NIH HHS R01 NS110890NINDS NIH HHS R56 NS110890NINDS NIH HHS R61 NS138655NINDS NIH HHS RF1 NS110890Rainwater Charitable FoundationTau ConsortiumWellcome Trust
6 · The paper itself

Abstract

introductionAfrica, home to 1.4 billion people and the highest genetic diversity globally, harbors unique genetic variants crucial for understanding complex diseases like neurodegenerative disorders. However, African populations remain underrepresented in induced pluripotent stem cell (iPSC) collections, limiting the exploration of population-specific disease mechanisms and therapeutic discoveries.

methodsTo address this gap, we established an open-access African Somatic and Stem Cell Bank.

resultsIn this initial phase, we generated 10 rigorously characterized iPSC lines from fibroblasts representing five Nigerian ethnic groups and both sexes. These lines underwent extensive profiling for pluripotency, genetic stability, differentiation potential, and Alzheimer's disease and Parkinson's disease risk variants. Clustered regularly interspaced palindromic repeats (CRISPR)/CRISPR-associated protein 9 technology was used to introduce frontotemporal dementia-associated MAPT mutations (P301L and R406W). DISCUSSION: This collection offers a renewable, genetically diverse resource to investigate disease pathogenicity in African populations, facilitating breakthroughs in neurodegenerative research, drug discovery, and regenerative medicine. HIGHLIGHTS: We established an open-access African Somatic and Stem Cell Bank. 10 induced pluripotent stem cell lines from five Nigerian ethnic groups were rigorously characterized. Clustered regularly interspaced palindromic repeats (CRISPR)/CRISPR-associated protein 9 technology was used to introduce frontotemporal dementia-causing MAPT mutations. The African Somatic and Stem Cell Bank is a renewable, genetically diverse resource for neurodegenerative research.

Indexed as

Biological Specimen BanksDementiaFrontotemporal DementiaInduced Pluripotent Stem CellsSub-Saharan African PeopleAlzheimer DiseaseBlack PeopleFemaleHumansMaleMutationNigeriatau ProteinsMAPT protein, humantau ProteinsAfrican ancestryAlzheimer's diseasecell bankclustered regularly interspaced palindromic repeats/CRISPR‐associated protein 9fibroblastsfrontotemporal dementiainduced pluripotent stem cellsParkinson's diseasepolygenic risk scores

Identifiers

PMID40219788
PMCPMC11992592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.